Neuroendovascular Coil Market Anticipated to Grow at 7.1% CAGR Through 2029: Industry Report

 This study helps professionals make sense of complex market trends and competitive shifts affecting the neuroendovascular coil industry today.

 

 What Is The Projected Market Size & Growth Rate Of The Neuroendovascular Coil Market?
 The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.29 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing incidence of neurovascular diseases, growing aging population, improved diagnostic technologies, expansion of neurointerventional facilities, awareness and education initiatives, regulatory approvals and standards.
 
 The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to continuous rise in neurovascular cases, expansion of neurointerventional services, focus on early intervention, global healthcare infrastructure growth, patient-centric care trends, international collaborations in research. Major trends in the forecast period include advancements in detachable neuroendovascular coils, rise in utilization of liquid embolics, development of bioactive and bioabsorbable coils, integration of dual-layer coil technologies, focus on flow diverters for aneurysm treatment.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13495&type=smp
 
 What Is The Crucial Factor Driving The Global Neuroendovascular Coil Market?
 The growing prevalence of neurovascular diseases is expected to propel the growth of the neuroendovascular coil market going forward. Neurovascular diseases affect the blood vessels supplying the nervous system, often leading to neurological symptoms and complications. Neuroendovascular coils are used in treating neurovascular diseases by being inserted into blood vessels to block off or stabilize abnormal blood vessel structures, reducing the risk of bleeding or other complications. For instance, in November 2023, according to a report published by the National Board of Health and Welfare (Socialstyrelsen), a Sweden-based government agency, in 2022, around 26,800 strokes were reported, impacting approximately 25,100 individuals. Among those who experienced a stroke that year, 12 percent died on the same day, 23 percent within 28 days, and 34 percent within one year. Therefore, the growing prevalence of neurovascular diseases is driving the growth of the neuroendovascular coil market. 
 
 Segment Covered In The Neuroendovascular Coil Market Report
 The neuroendovascular coil market covered in this report is segmented — 
 
 1) By Product Type: Guglielmi Detachable Coils (GDCs), Matrix Coils
 2) By Indication: Ruptured Aneurysm, Unruptured Aneurysm
 3) By Application: Tumor Surgery, Medical Teaching
 4) By End User: Hospitals, Ambulatory Surgical Centers (ASCs), Stroke Centers, Other End Users
 
 Subsegments:
 1) By Guglielmi Detachable Coils (GDCs): Soft GDCs, Standard GDCs, Detachable GDCs With Various Configurations 
 2) By Matrix Coils: Soft Matrix Coils, Coated Matrix Coils, Detachable Matrix Coils, Flow Diverter Matrix Coils
 
 Key Trends Driving Growth In The Neuroendovascular Coil Market
 Major companies operating in the neuroendovascular coil market are focused on developing soft and unique-shaped coils to gain a competitive edge in the market. In neuroendovascular procedures, soft and unique shapes, such as tetrahedral coils, enhance aneurysm treatment by conforming to vessel anatomy, reducing complications, and improving patient outcomes, especially in complex cases. For instance, in December 2022, Stryker Corporation, a US-based medical technology company that manufactures neuroendovascular coils, launched the Target Tetra Detachable Coil, which combines a new tetrahedral shape and softness level and is specifically designed to treat small aneurysms. It provides a 2-in-1 feature with a unique tetrahedral shape that allows stability in wide-necked aneurysms and a soft helical tail. This shape offers strong memory and is soft at the same time, making it a good choice for treating small aneurysms.
 
 Key Player In The Neuroendovascular Coil Market
 Major companies operating in the neuroendovascular coil market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Cook Group Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Minnetronix Medical Inc., SurModics Inc., Galen Medical Group P.C, Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Allium Medical Solutions Ltd., Shape Memory Medical Inc., InnoCore Pharmaceuticals BV, Wuhan HNC Technology Co. Ltd., Neural Co. Ltd., Three Rivers Medical Inc.
 
 View the full neuroendovascular coil market report here:
 https://www.thebusinessresearchcompany.com/report/neuroendovascular-coil-global-market-report
 
 Global Neuroendovascular Coil Market — Regional Insights:
 North America was the largest region in the neuroendovascular coil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company